Predictive value analysis of CEA, CA125 and CYFRA21-1 levels in evaluating the efficacy of tislelizumab combined with gemcitabine-cisplatin chemotherapy in patients with advanced non-small cell lung cancer. [PDF]
Wang L, Gou T, Cui Y, Li M, Wang Y.
europepmc +1 more source
A quantitative immunoassay for lung cancer biomarker CIZ1b in patient plasma [PDF]
Ainscough, Eve +8 more
core +1 more source
Assessment of diagnostic efficacy: High fluorescent cells combined with CEA, NSE, and Cyfra21-1 in Malignant Pleural Effusion Identification. [PDF]
Zhang N +8 more
europepmc +1 more source
Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients [PDF]
Ana Lourdes González-Piñeiro +5 more
core +1 more source
CYFRA21-1/TG ratio as an accurate risk factor to predict eye metastasis in nasopharyngeal carcinoma: A STROBE-compliant article. [PDF]
Peng SJ +9 more
europepmc +1 more source
Key messages of recent publications in the field of toxicology [PDF]
Cadenas, C. +5 more
core +2 more sources
Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1. [PDF]
Wang J, Tang X, Liu X, Zhang J.
europepmc +1 more source
The Current Research Feature and Prospect of Bronchoalveolar Lavage in Diagnosing Lung Cancer [PDF]
Weimin DING, Wentao YUE, Yu FU
core

